Profile
TAK ZTS HLN TEVA ITCI NBIX
Company Name Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc. Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $45.60B $65.61B $43.38B $18.77B $14.05B $12.30B
Employees 49.28K 13.80K 24.56K 37.00K 0.86K 1.80K
CEO Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Sharon Mates Kyle W. Gano
Ratings
TAK ZTS HLN TEVA ITCI NBIX
Quant Rating Score 3 3 3 2 1 4
Quant Rating Neutral Neutral Neutral Sell Strong Sell Buy
Trading
TAK ZTS HLN TEVA ITCI NBIX
Last Close $14.63 $149.77 $9.58 $16.6 $131.87 $128.89
High 52 $15.46 $196.48 $11.41 $22.77 $131.91 $153.29
Low 52 $12.89 $144.45 $9.01 $12.82 $71.19 $87.59
Price vs. 52 Week High -5.37 % -23.77 % -16.04 % -27.1 % -0.03 % -15.92 %
Price vs. 52 Week Low 13.5 % 3.68 % 6.33 % 29.49 % 85.24 % 47.15 %
Total Return
TAK ZTS HLN TEVA ITCI NBIX
1 Month Return -0.34 % -3.35 % -3.82 % 1.22 % 0 % -3.42 %
3 Month Return 6.63 % -6.63 % -8.33 % -5.03 % 0 % 10.28 %
6 Month Return 7.42 % -9.19 % -3.72 % -0.18 % 2.98 % 10.28 %
9 Month Return 7.89 % -15.4 % 3.79 % -2.01 % 49.48 % 2.69 %
YTD Return 10.5 % -8.08 % 0.42 % -24.68 % 57.89 % -5.58 %
1 Year Return 4.05 % -20.5 % -2.04 % -3.09 % 75.06 % -14.47 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TAK ZTS HLN TEVA ITCI NBIX
Dividend Yield Percentage (TTM) 4.6 % 1.31 % 0.02 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 2.03 % 2 % - 2.78 % -227.26 % 14.7 %
Dividend Per Share (TTM) 196 % 1.93 % 0.05 % - - -
Payout Ratio (TTM) 226.17 % 32.25 % - - - -
Profitability
TAK ZTS HLN TEVA ITCI NBIX
Gross Profit Margin TTM 60.54 % 70.2 % 61.52 % 49.6 % 91.63 % 98.49 %
Return on Assets TTM 0.98 % 17.86 % 4.2 % -0.39 % -5.46 % 8.95 %
Return on Equity TTM 1.95 % 51.32 % 8.74 % -2.58 % -7.4 % 13.22 %
Return on Capital Employed TTM 3.43 % 32.08 % 7.74 % 3.16 % -10.05 % 14.8 %
Net Income Per EBT TTM 72.1 % 78.79 % 75.5 % 222.54 % 100.64 % 66.08 %
EBT Per Ebit TTM 46.84 % 92.99 % 86.58 % -7.94 % 63.57 % 106.48 %
EBIT Per Revenue TTM 9.05 % 37.01 % 19.64 % 5.38 % -17.15 % 19.72 %
Cash Flow To Debt Ratio TTM 23.79 % 43.63 % - 7.93 % -430.93 % 129.2 %
Receivables Turnover TTM 6.59 6.82 5.9 4.67 4.09 4.21
Payables Turnover TTM 4.53 6.51 2.19 3.35 2.18 0.36
Inventory Turnover TTM 1.54 1.16 3.63 2.4 2.17 0.66
Fixed Asset Turnover TTM 229.02 % 253.65 % 584.75 % 321.73 % 4569.25 % 429.78 %
Asset Turnover TTM 31.99 % 65.87 % 32.73 % 41.43 % 49.79 % 64.53 %
Operating Cash Flow Per Share TTM 684.97 6.58 - 1.21 -0.71 5.73
Free Cash Flow Per Share TTM 531.34 5.1 - 0.78 -0.71 5.34
Cash Per Share TTM 26788.97 % 384.5 % 24.05 % 188.4 % 970.67 % 985.45 %
Operating Cash Flow Sales Ratio TTM 23.92 % 31.71 % - 8.36 % -10.75 % 22.6 %
Free Cash Flow Operating Cash Flow Ratio TTM 77.57 % 77.45 % - 64.03 % 100.44 % 93.2 %
Cash Flow Coverage Ratios TTM 23.79 % 43.63 % - 7.93 % -430.93 % 129.2 %
Price To Free Cash Flows Ratio TTM 8.01 28.77 - 21.16 -191.12 23.26
Price To Operating Cash Flows Ratio TTM 6.23 22.4 - 13.55 -185.85 21.64
Price Cash Flow Ratio TTM 6.23 22.4 - 13.55 -185.85 21.64
Income Statement (TTM)
TAK ZTS HLN TEVA ITCI NBIX
Revenue $4581.55B $9.26B $11.23B $16.54B $0.68B $2.36B
Gross Profit $3001.33B $6.4B $6.95B $8.06B $0.62B $2.32B
Gross Profit Ratio 65.51% 69.1% 61.85% 48.74% 91.63% 98.56%
EBITDA $1210.51B $3.87B $2.51B $0.78B $-0.12B $0.64B
Net Income $107.93B $2.49B $1.44B $-1.64B $-0.07B $0.34B
EPS Diluted 33.62 5.47 0.32 -1.45 -0.72 3.29
Balance Sheet (MRQ)
TAK ZTS HLN TEVA ITCI NBIX
Long Term Debt $4517.23B $5.39B $8.54B $16.3B $0.01B $0.46B
Total Liabilities $7312.37B $9.47B $18.09B $33.61B $0.22B $1.13B
Total Equity $6935.98B $4.77B $16.22B $5.72B $1.15B $2.59B
Total Investments $10.8B $0B $0.08B $0B $0.69B $1.71B
Total Debt $5066.17B $6.74B $10.1B $18.08B $0.02B $0.46B
Total Assets $14248.34B $14.24B $34.32B $39.33B $1.37B $3.72B
Cash Flow Statement (TTM)
TAK ZTS HLN TEVA ITCI NBIX
Net Income $107.93B $2.5B $1.44B $-1.96B $-0.07B $0.34B
Inventory $-34.97B $-0.04B $0.22B $0.17B $-0.01B $-0.02B
Dividends Paid $-302.5B $-0.79B $-0.57B $0B $0B $0B
Operating Cash Flow $1057.18B $2.95B $2.3B $1.25B $-0.07B $0.6B
Capital Expenditure $-200.8B $-0.66B $-0.25B $-0.5B $-0B $-0.04B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 5.535
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.38
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9
ALVOW Alvotech 1.48
AMPH Amphastar Pharmaceuticals, Inc. 30.48
AMRX Amneal Pharmaceuticals, Inc. 9.41
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 88.665
APUS Apimeds Pharmaceuticals US, Inc 1.621
AQST Aquestive Therapeutics, Inc. 4.015
ASRT Assertio Holdings, Inc. 0.8123
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 13.79
ETFs With Exposure to TAK
Ticker ETF Name Weight Percentage Price
VEU Vanguard FTSE All-World ex-US Index Fund 0.00226 69.515
FVD First Trust Value Line Dividend Index Fund 0.41 46.295
CVY Invesco Zacks Multi-Asset Income ETF 0.435 26.62
GCOW Pacer Global Cash Cows Dividend ETF 0.74 39.86
AFTY Pacer CSOP FTSE China A50 ETF 0.27 16.2826
AGGY WisdomTree Yield Enhanced U.S. Aggregate Bond Fund 0.04 43.86
FPXI First Trust International Equity Opportunities ETF 2.11 57.18
ICOW Pacer Developed Markets International Cash Cows 100 ETF 1.77 35.725
PPH VanEck Pharmaceutical ETF 2.96 85.285
VETS Pacer Military Times Best Employers ETF 0.18 38.62
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.37 33.28
PTIN Pacer Trendpilot International ETF 0.18 29.74
VALT ETFMG Sit Ultra Short ETF 0.77 48.52
SLT Pacer Salt High truBeta US Market ETF 0.18 39.22
LSLT Pacer Salt Low truBeta US Market ETF 0.18 32
AVDE Avantis International Equity ETF 0.06 76.745
GERM ETFMG Treatments, Testing and Advancements ETF 0.89 19.1577
VIRS Pacer BioThreat Strategy ETF 0.18 40.025
FVL First Trust Value Line 100 Exchange-Traded Fund 0.41 23.1559
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.73 1.75
RTL The Necessity Retail REIT, Inc. 0.27 7.61
BAD B.A.D. ETF 1.51 11.91
AVSD Avantis Responsible International Equity ETF 0.06 69.7994
DFIC Dimensional International Core Equity 2 ETF 0.00101746 32.165
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0.00226 42.86
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.00084262 30.58
TRPL Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF 0.18 41.14
OZEM Roundhill GLP-1 & Weight Loss ETF 1.92 24.57
CGCV Capital Group Conservative Equi 0.1 29.385
ENDW Cambria Endowment Style ETF 0 29.305
Unlock